[Not Available].
作者信息
Klimek Ludger, Bergmann Karl-Christian, Brehler Randolf, Pfützner Wolfgang, Worm Margitta, Hartmann Karin, Jakob Thilo, Novak Natalija, Ring Johannes, Hamelmann Eckard, Ankermann Tobias, Schmidt Sebastian M, Untersmayr Eva, Hötzenecker Wolfram, Jensen-Jarolim Erika, Zuberbier Torsten
机构信息
Zentrum f. Rhinologie und Allergologie, An den Quellen 10, 65183 Wiesbaden, Germany.
Allergie-Centrum-Charite (Charite Campus Mitte), Luisenstr. 2-5, 10117 Berlin, Germany.
出版信息
Allergo J. 2021;30(3):22-43. doi: 10.1007/s15007-021-4773-1. Epub 2021 May 7.
Abstract
摘要
相似文献
1
[Not Available].[不可用]。
Allergo J. 2021;30(3):22-43. doi: 10.1007/s15007-021-4773-1. Epub 2021 May 7.
引用本文的文献
1
[Allergen immunotherapy: FAQs and facts].[变应原免疫疗法：常见问题与事实]
Hautarzt. 2021 Sep;72(9):760-769. doi: 10.1007/s00105-021-04872-8. Epub 2021 Aug 17.
2
[Not Available].[无可用内容]。
Allergo J. 2021;30(5):24-33. doi: 10.1007/s15007-021-4846-1. Epub 2021 Aug 13.
本文引用的文献
1
COVID-19 vaccine anaphylaxis: PEG or not?新冠病毒疫苗过敏反应：聚乙二醇相关与否？
Allergy. 2021 Jun;76(6):1934-1937. doi: 10.1111/all.14722.
2
Allergenic components of the mRNA-1273 vaccine for COVID-19: Possible involvement of polyethylene glycol and IgG-mediated complement activation.mRNA-1273 疫苗中 COVID-19 的过敏原成分：可能涉及聚乙二醇和 IgG 介导的补体激活。
Allergy. 2021 Nov;76(11):3307-3313. doi: 10.1111/all.14794. Epub 2021 Jun 17.
3
Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA: Position statement of the German Allergy Societies: Medical Association of German Allergologists (AeDA), German Society for Allergology and Clinical Immunology (DGAKI) and Society for Pediatric Allergology and Environmental Medicine (GPA).英国和美国接种辉瑞/生物科技公司新冠疫苗后出现的严重过敏反应：德国过敏学会立场声明：德国过敏症专科医生医学协会（AeDA）、德国过敏与临床免疫学会（DGAKI）以及儿童过敏与环境医学学会（GPA）
Allergo J Int. 2021;30(2):51-55. doi: 10.1007/s40629-020-00160-4. Epub 2021 Feb 24.
5
mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis.mRNA新冠疫苗在患有皮肤和全身性肥大细胞增多症且伴有肥大细胞活化症状和过敏反应的患者中耐受性良好。
J Allergy Clin Immunol. 2021 Mar;147(3):877-878. doi: 10.1016/j.jaci.2021.01.004. Epub 2021 Jan 19.
6
Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020.美国 2020 年 12 月 14 日至 23 日：在接种第一剂辉瑞-BioNTech COVID-19 疫苗后出现过敏反应（包括过敏反应）。
MMWR Morb Mortal Wkly Rep. 2021 Jan 15;70(2):46-51. doi: 10.15585/mmwr.mm7002e1.
7
Clinical manifestations and impact on daily life of allergy to polyethylene glycol (PEG) in ten patients.十名对聚乙二醇（PEG）过敏患者的临床表现及对日常生活的影响。
Clin Exp Allergy. 2021 Mar;51(3):463-470. doi: 10.1111/cea.13822. Epub 2021 Jan 15.
8
Assessing vaccination reactions in pediatric patients with maculopapular cutaneous mastocytosis.评估小儿肥大细胞增多症患者斑丘疹性皮肤肥大细胞瘤的疫苗反应。
Pediatr Dermatol. 2021 Mar;38(2):502-503. doi: 10.1111/pde.14492. Epub 2021 Jan 3.
9
Pfizer's vaccine raises allergy concerns.辉瑞公司的疫苗引发了人们对过敏的担忧。
Science. 2021 Jan 1;371(6524):10-11. doi: 10.1126/science.371.6524.10.
10
ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines - An EAACI-ARIA Position Paper.ARIA-EAACI 关于 COVID-19 疫苗严重过敏反应的声明——一份 EAACI-ARIA 立场文件。
Allergy. 2021 Jun;76(6):1624-1628. doi: 10.1111/all.14726.
Zotero 插件